Canada is experiencing a toxic drug supply crisis that has killed tens of thousands of Canadians since 2016. The deaths are not random. They cluster among people with substance-use disorders, often compounded by poverty, trauma, housing instability, and under-treated mental illness. The primary driver of overdose deaths is the unregulated illicit drug supply — increasingly contaminated with fentanyl, carfentanil, and toxic adulterants — not drug use itself.
A policy response calibrated to this reality looks different from a policy response calibrated to moral disapproval of drug use. This article is based on the first premise: that saving lives and reducing harm are the objectives, and that evidence determines what achieves them.
This article does not endorse unregulated access to all substances. It endorses treating addiction as a health condition, applying evidence to intervention design, and being honest about what decades of criminalisation have and have not achieved.
1. Substance-use disorders are health conditions, not moral failures. People with addiction deserve the same quality of health care as people with any other chronic condition. Policy that denies this — through criminalisation, stigma, or refusal to fund treatment — causes harm and does not reflect the medical evidence.
2. Harm reduction saves lives now; treatment addresses long-term recovery. These are complementary, not competing. Supervised consumption services, naloxone distribution, and drug checking services prevent overdose deaths in the short term. Treatment, recovery housing, and long-term support address the underlying condition. Both are necessary; one without the other is insufficient.
3. The criminal justice system is not a health care system. People experiencing addiction who encounter criminal justice — whether through arrest, incarceration, or coerced treatment — have worse outcomes than those who access voluntary health care. Decriminalisation of personal possession, properly implemented, reduces harm without increasing use rates. The evidence from Portugal, British Columbia, and other jurisdictions is clear.
4. The toxic supply is the primary killer. Most overdose deaths involve the illicit unregulated drug supply, not regulated pharmaceuticals. A supply-side response — including regulated safer supply programs — addresses the specific mechanism causing deaths. This is evidence- based, not ideological.
5. Response must reach people where they are. People who need services most are often hardest to reach through conventional service models. Outreach, low-barrier access, mobile services, and peer-led programs consistently reach populations that clinic-based models do not.
Emergency response coordination Recognise the toxic drug supply crisis as an ongoing federal public health emergency with dedicated federal coordination, data infrastructure, and funding. Coordinate national response across Health Canada, Public Health Agency of Canada, and provincial health authorities with quarterly public reporting on deaths, service capacity, and policy implementation status.
Harm reduction services — national funding floor Establish a federal funding floor for harm reduction services, including: supervised consumption sites, drug checking services, naloxone distribution and training, and outreach services. Funding requires evidence-based program design and outcome reporting. Provinces and territories are responsible for service delivery; federal funding is conditional on meeting minimum service availability benchmarks.
Expanded rapid access to treatment Fund and expand Rapid Access to Addiction Medicine (RAAM) clinics as the national model for low-barrier treatment entry. Targets: same-day or next-day access without referral, pharmacotherapy availability on first visit for opioid use disorder, and connection to ongoing care. Wait time data for treatment services is published quarterly by province.
Safer supply programs — evidence-based expansion Sustain and expand regulated safer supply programs where evidence supports them — particularly for opioid use disorder in communities with high contamination risk in the illicit supply. Program design requires medical oversight, outcome monitoring, and participant consent. Evidence review cycles publish outcome data annually and inform program adjustments.
Mental health and addiction integration Require that federal transfers supporting addiction treatment include co-located or formally integrated mental health services. Comorbid mental illness and addiction are the norm, not the exception, in people with severe substance-use disorders. Fragmented service delivery produces gaps that are expensive in both human and financial terms.
Recovery housing Fund a national recovery housing program with per-unit subsidies for non-profit operators providing stable, substance-free or harm-reduction- informed housing with peer support for people in long-term recovery. Recovery housing is distinct from emergency shelter. Outcome tracking covers tenancy retention, health engagement, and community connection.
Decriminalisation of personal possession Support a federal decriminalisation framework for personal possession of drugs for personal use — eliminating criminal records as a barrier to employment, housing, and health care, while maintaining trafficking and supply offences. Evaluate British Columbia's pilot data and implement national framework with provincial coordination. Expunge criminal records for simple possession offences.
- Overdose death rates decline in jurisdictions with full harm-reduction and safer supply program implementation, tracked against pre-intervention baselines.
- Treatment wait times: 80% of people seeking opioid agonist therapy access it within 48 hours in participating jurisdictions within three years.
- Naloxone distribution reaches measurable coverage benchmarks in all provinces and territories within two years.
- Recovery housing units funded under federal program increase annually with tenancy retention rates published.
- Mental health and addiction co-location targets are met in 100% of new RAAM clinic funding within two years.
- National drug poisoning death data is published monthly, disaggregated by region, substance, and demographic factors.
- Criminal records expunged for personal possession offences within two years of decriminalisation framework implementation.